Rupatadine fumarate
- Level
- Commodity
- Parent
- 51312200
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51312210This classification denotes a histamine-1 receptor antagonist C26H26ClN3.C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XJ6OT32M93, chemically known as 5h-benzo(5,6)cyclohepta(1,2-b)pyridine, 8-chloro-6,11-dihydro-11-(1-((5-methyl-3-pyridinyl)methyl)-4-piperidinylidene)-, (2e)-2-butenedioate (1:1), but more generally known as rupatadine fumarate, which bears US NIH Compound Identifier 6449107. European Medicines Agency schedules Rupatadine fumarate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB22090. Most nations, for tariff and trade purposes, schedule rupatadine fumarate under HS 29333999 and SITC 51574. As of Q4 2014, RUPATADINE FUMARATE remains US FDA's Preferred Term for this commodity. SMILES: CC1CC(CNC1)CN2CCC(=C3C4CCC(CC4CCC5C3NCCC5)CL)CC2.C(=C/C(=O)O)\C(=O)O.
Same parent
Under 51312200 · 10Activities that produce or sell this
KBLI · 9Inherited from family 51310000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.